Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2014 Mar 4;9(3):e90501. doi: 10.1371/journal.pone.0090501

Prevalence of Disorders Recorded in Dogs Attending Primary-Care Veterinary Practices in England

Dan G O′Neill 1,*, David B Church 2, Paul D McGreevy 3, Peter C Thomson 3, Dave C Brodbelt 1
Editor: Cheryl S Rosenfeld4
PMCID: PMC3942437  PMID: 24594665

Abstract

Purebred dog health is thought to be compromised by an increasing occurence of inherited diseases but inadequate prevalence data on common disorders have hampered efforts to prioritise health reforms. Analysis of primary veterinary practice clinical data has been proposed for reliable estimation of disorder prevalence in dogs. Electronic patient record (EPR) data were collected on 148,741 dogs attending 93 clinics across central and south-eastern England. Analysis in detail of a random sample of EPRs relating to 3,884 dogs from 89 clinics identified the most frequently recorded disorders as otitis externa (prevalence 10.2%, 95% CI: 9.1–11.3), periodontal disease (9.3%, 95% CI: 8.3–10.3) and anal sac impaction (7.1%, 95% CI: 6.1–8.1). Using syndromic classification, the most prevalent body location affected was the head-and-neck (32.8%, 95% CI: 30.7–34.9), the most prevalent organ system affected was the integument (36.3%, 95% CI: 33.9–38.6) and the most prevalent pathophysiologic process diagnosed was inflammation (32.1%, 95% CI: 29.8–34.3). Among the twenty most-frequently recorded disorders, purebred dogs had a significantly higher prevalence compared with crossbreds for three: otitis externa (P = 0.001), obesity (P = 0.006) and skin mass lesion (P = 0.033), and popular breeds differed significantly from each other in their prevalence for five: periodontal disease (P = 0.002), overgrown nails (P = 0.004), degenerative joint disease (P = 0.005), obesity (P = 0.001) and lipoma (P = 0.003). These results fill a crucial data gap in disorder prevalence information and assist with disorder prioritisation. The results suggest that, for maximal impact, breeding reforms should target commonly-diagnosed complex disorders that are amenable to genetic improvement and should place special focus on at-risk breeds. Future studies evaluating disorder severity and duration will augment the usefulness of the disorder prevalence information reported herein.

Introduction

The domestic dog (Canis lupus familiaris) has become integral to modern human family life, with the UK dog population estimated to be 8–10 million [1], [2], [3] and 24–31% of UK households estimated to own at least one dog [1], [2]. Although humans benefit from dog ownership both physically [4], [5] and mentally [6], [7], it is increasingly questioned whether modern breeding practices have allowed dog health and welfare to derive comparable benefits [8], [9]. Although the dog is now the most phenotypically diverse mammal at a species level [10], genetic diversity has been greatly reduced within modern breeds [11] because of breeding practices that include closed stud books [12], structured inbreeding [11] and reproductive dominance of popular sires [13]. Additionally, selection pressure within breeds towards phenotypic exaggeration driven by breed standards [8], have increased the potential for conformation-associated disease [14]. Each of the 50 most popular breeds in the UK has at least one reported conformational predisposition to disease [15] and almost 400 non-conformational inherited disorders have been identified [16]. Conversely, implicit acceptance of the statement that purebred dogs are plagued with many inherited diseases [17] has contributed to a widespread belief that crossbred dogs are substantially healthier than purebreds [18].

Following claims in the BBC documentary Pedigree Dogs Exposed that purebred dog health was deteriorating because of inbreeding and ill-advised breed standards [19], three major reports concurred that pedigree breeding practices did impose welfare costs on dogs but, more crucially, concluded that a critical data gap on disorder prevalence information in UK dogs constrained effective reforms [20], [21], [22]. Prevalence data have been published on only 1% of inherited disorders affecting popular UK dog breeds [23]. Effective welfare reform of pedigree dog-breeding must be underpinned by scientifically valid prioritisation of disorders based on reliable and comparable prevalence data [12], [24]. However, differing case definitions, study populations, geographical locations, data quality and data collection periods between published studies, combined with substantial data gaps, have constrained efforts to prioritise disorders in domestic dogs [9]. Application of health data collected via a single national surveillance system has been proposed for effective disorder prioritisation, with the critical first step being the generation of reliable disorder prevalence values [12].

Systematised collection, mergence and analysis of electronic patient record (EPR) data from primary-care veterinary practices has been proposed for generation of reliable prevalence data relating to the overall dog population [12], [20]. Contemporaneous recording of clinical information by veterinary health professionals during episodes of care for every patient treated minimises selection and recall biases in primary-care practice EPR data [20]. By contrast, referral caseloads may show selection bias towards more complicated disorders [25], questionnaire surveys may incur selection, recall and misclassification biases [26], and pet insurance data are limited by selection bias emerging from age restrictions, financial excesses and owner attributes [27].

This study aimed to use a database of merged primary-care practice EPRs to estimate the prevalence of the most frequently recorded disorders and syndromes in dogs attending primary-care veterinary practices in England. The study further aimed to evaluate associations between the occurrence of common disorders with purebred/crossbred status and with popular breeds. It was hypothesised that purebred dogs have a higher prevalence of common disorders compared with crossbred dogs.

Materials and Methods

Ethics statement: Ethics approval was granted by the RVC Ethics and Welfare Committee (reference number 2010 1076).

The VetCompass Animal Surveillance project collates de-identified EPR data from primary-care veterinary practices in the UK for epidemiological research [28]. The current study included data collected from all clinics within the Medivet Veterinary Group, a large network of integrated veterinary practices covering central and south-eastern England [29]. Practitioners recorded summary diagnosis terms from an embedded standard nomenclature, the VeNom codes [30], at episodes of clinical care. EPR data were extracted from practice management systems (PMSs) using integrated clinical queries [31] and uploaded to a secure structured query language (SQL) database. Information collected included patient demographic (animal identification number, species, breed, date of birth, sex, neuter status, insurance status, microchip number and weight) and clinical information (free-form text clinical notes, VeNom summary diagnosis terms and treatment, with relevant dates) data fields.

The study sampling frame included all dogs that had at least one EPR (clinical note, weight recording or treatment dispensed) recorded within the VetCompass Animal Surveillance database from September 1, 2009 to March 31, 2013. Sample size calculations estimated that, from a study population of 140,000 dogs, a sample of 3,648 animals was required to represent a disorder with 2.5% expected frequency with a precision of 0.5% at a 95% confidence level [32].

A random sample of dogs was selected from the overall sampling frame using an online random number generator (www.random.org). Clinical notes and VeNom summary diagnosis terms recorded during the study period were reviewed in detail, and the most definitive diagnostic term recorded for each disorder diagnosed within individual dogs was manually coded using the most appropriate VeNom term. Elective (e.g. neutering) or prophylactic (e.g. vaccination) clinical events were not included. Multiple counting of disorder events for ongoing cases was avoided by including recurring diagnoses of ongoing conditions only once (e.g. repeated events of otitis externa) and by including only the final diagnosis term recorded in cases with diagnosis revision over time (e.g. following clinical work-up or trial therapy), based on the assumption that diagnostic accuracy increased over time [33]. The parent term was used for disorders that encompassed multiple child terms [34] (e.g. a parent term road traffic accident (RTA) may have multiple child terms such as laceration, fracture and hypovolaemic shock). Disorder events that were aetiologically independent despite sharing the same disorder term name (e.g. novel traumatic events) were included separately. No distinction was made between pre-existing and incident disorder presentations. Disorders described within the clinical notes using presenting sign terms (e.g. ‘vomiting and diarrhoea’), but without a formal clinical diagnostic term being recorded, were included using the first sign listed (e.g. vomiting). Dental disorders were included only if surgical or medical intervention were recommended.

Recognisable single breeds [35] were grouped as ‘purebred’ while all other dogs were grouped as ‘crossbred’. Purebreds were further categorised by Kennel Club (KC) breed-recognition (recognised/not recognised) and KC breed group (gundog, hound, pastoral, terrier, toy, utility, working) [36]. Neuter status was defined by the final EPR neuter value and was combined with sex to create four categories: female entire, female neutered, male entire and male neutered. Insurance and microchip values characterized the existence of a positive status at any time during the study period. The maximum bodyweight (kg) recorded for dogs aged over one year was categorised into seven groups (<10.0, 10.0–19.9, 20.0–29.9, 30.0–39.9, 40.0–49.9, ≥50.0, and ‘no recorded weight’). The age (years) at the final EPR was categorised into five groups (<1.0, 1.0–2.9, 3.0–5.9, 6.0–9.9, ≥10.0). Time contributed to the study for each dog was calculated as the period from the date of the earliest EPR to the date of the latest EPR. The date and manner (euthanasia or non-assisted) [37] of deaths recorded during the study were identified.

VeNom diagnostic terms for all recorded disorders were extracted and mapped to three systems of terms for analysis: diagnosis-level precision, mid-level precision and syndromic classification. Diagnosis-level terms were one-to-one descriptors of the original extracted terms at the maximal diagnostic precision recorded within the clinical notes (e.g. inflammatory bowel disease would remain as inflammatory bowel disease). Mid-level precision terms were one-to-one descriptors of original diagnosis terms defined at a general level of diagnostic precision (e.g. inflammatory bowel disease would map to enteropathy). Syndromic classification used three taxonomic groupings: body location, organ system and pathophysiologic process. The number of syndromic terms that could be mapped from each original diagnostic term was not limited.

Study data were exported from the VetCompass database to a spreadsheet (Microsoft Office Excel 2007, Microsoft Corp.) for checking and cleaning before further export to Stata Version 11.2 (Stata Corporation) for statistical analyses. Demographic variables were described statistically for the overall study population and the sample group. Prevalence values with 95% confidence intervals (CI) were tabulated for the twenty most prevalent diagnosis-level and mid-level disorders and for all syndromic terms, and were reported across all sampled dogs, purebreds only and crossbreds only. Prevalence values for purebred and crossbred dogs were compared statistically using the chi-squared test with Holm-adjusted P-values to account for multiple testing effects [38]. Statistical significance was set at the 5% level. The CI estimates were derived from standard errors based on approximation to the normal distribution for disorders with ten or more events recorded [39], but the Wilson approximation method was used for disorders with fewer than ten events recorded [40]. Prevalence (95% CI) values for the twenty most prevalent diagnosis-level and mid-level disorders and for all syndromic terms were similarly derived, reported and compared for popular breeds and crossbreds (popular breeds had ≥100 dogs in the sample group).

Results

The overall population comprised 148,741 dogs attending 93 clinics across central and south-eastern England. Demographic examination of dogs with information available indicated that 117,179 (78.9%) were purebred, 71,002 (48.0%) were female, 61,120 (41.1%) were neutered, 43,435 (29.2%) were insured and 41,071 (27.6%) were microchipped. The median weight was 18.2 kg (interquartile range (IQR): 9.4–29.0, range: 0.68–105.0) and the median age was 4.5 years (IQR: 1.6–8.7, range: 0.0–27.4) (Table 1).

Table 1. Demographic information for sampled (n = 3,884) and overall study population (n = 148,741) dogs attending primary veterinary practices in England.

Variable Category Sample: No. (%) Population: No. (%)
Sex/neuter Female entire 981 (25.4) 40,514 (27.4)
Female neutered 836 (21.6) 30,488 (20.6)
Male entire 1,152 (29.8) 46,459 (31.4)
Male neutered 899 (23.2) 30,635 (20.7)
Microchip Not microchipped 2,733 (70.4) 107,670 (72.4)
Microchipped 1,151 (29.6) 41,071 (27.6)
Purebred status Crossbred 797 (20.6) 31,354 (21.1)
Purebred 3,079 (79.4) 117,179 (78.9)
Popular breeds Crossbreed 797 (20.5) 31,354 (21.1)
Labrador Retriever 339 (8.7) 13,328 (9.0)
Staffordshire Bull Terrier 334 (8.6) 12,212 (8.2)
Jack Russell Terrier 262 (6.8) 10,006 (6.7)
Cocker Spaniel 133 (3.4) 5,579 (3.8)
German Shepherd Dog 132 (3.4) 5,314 (3.6)
Yorkshire Terrier 127 (3.3) 4,880 (3.3)
Border Collie 104 (2.7) 3,997 (2.7)
Other named breeds 1,656 (42.6) 62,071 (41.7)
KC a - breed b Not KC-recognised 306 (9.9) 11,717 (10.0)
KC-recognised 2,773 (90.1) 105,462 (90.0)
KC a group c Gundog 737 (26.6) 28,832 (27.3)
Hound 178 (6.4) 6,505 (6.2)
Pastoral 284 (10.2) 11,530 (10.9)
Terrier 561 (20.2) 21,481 (20.4)
Toy 474 (17.1) 17,215 (16.3)
Utility 330 (11.9) 11,573 (11.0)
Working 209 (7.5) 8,326 (7.9)
Weight (kg) No recorded weight 1,260 (32.4) 52,308 (35.2)
<10.0 769 (19.8) 26,786 (18.0)
10.0–19.9 695 (17.9) 25,278 (17.0)
20.0–20.99 579 (14.9) 21,869 (14.7)
30.0–30.9 390 (10.0) 15,255 (10.3)
40.0–40.9 130 (3.4) 5,118 (3.4)
≥50.0 61 (1.6) 2,127 (1.4)
Age (years) <1.0 588 (15.2) 24,915 (16.8)
1.0–2.9 791 (20.4) 30,747 (20.7)
3.0–5.9 877 (22.6) 33,500 (22.5)
6.0–9.9 811 (20.9) 30,811 (20.7)
≥10.0 814 (21.0) 28,664 (19.3)
Insurance Non-insured 2,658 (68.4) 105,306 (70.8)
Insured 1,226 (31.6) 43,435 (29.2)
a

KC The Kennel Club.

b

Percentage values based on purebred only.

c

Percentage values based on KC-recognised dogs only.

The study sample comprised 3,884 dogs attending 89 clinics. Of dogs with information available, 3,079 (79.4%) were purebred, 1,817 (47.0%) were female, 1,735 (44.7%) were neutered, 1,226 (31.6%) were insured and 1,151 (29.6%) were microchipped. The median weight was 17.3 kg (IQR: 9.1–28.4, range: 1.3–100.6) and the median age was 4.8 years (IQR: 1.8–9.1, range: 0.0–21.24). The most popular seven breeds accounted for 1,431 (36.8%) of the study sample dogs (Table 1). Of the sampled dogs, 378 (9.7%) died during the study period, with a median (IQR, range) age at death of 12.3 years (9.2–14.4, 0.0–21.0) and 336 (88.9%) deaths involving euthanasia. Overall, 2,945 (75.8%) dogs had at least one disorder diagnosed, with the remainder having no disorders diagnosed during the study period. The median (IQR, range) number of disorders diagnosed per dog was 1.0 (1.0–3.0, 0.0–21.0). The median (IQR, range) time contributed to the study per dog was 0.7 years (0.0–3.5, 0.0–1.9). The sample and study populations were similar across all measures assessed.

Among the sampled dogs, 8,025 unique disorder events were recorded encompassing 430 distinct diagnosis-level disorder terms. The most prevalent diagnosis-level disorders recorded were otitis externa (number of events: 396, prevalence: 10.2%, 95% CI: 9.1–11.3), periodontal disease (361, 9.3%, 95% CI: 8.3–10.3), anal sac impaction (277, 7.1%, 95% CI: 6.1–8.1) and overgrown nails (276, 7.1%, 95% CI: 6.1–8.2). Purebred dogs had a significantly higher prevalence compared with crossbreds for three of the twenty most-prevalent diagnosis-level disorders: otitis externa (P = 0.001), obesity (P = 0.006) and skin mass lesion (P = 0.033) (Table 2). The prevalence of five of the twenty most-prevalent diagnosis-level disorders differed statistically significantly between popular breeds: periodontal disease (P = 0.002), overgrown nails (P = 0.004), degenerative joint disease (P = 0.005), obesity (P = 0.001) and lipoma (P = 0.003) (Table 3).

Table 2. Prevalence results for the most frequent disorders recorded in dogs, purebreds only and crossbreds only that attended primary veterinary practices in England.

Overall Purebred Crossbred
Disorder No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P-value
Otitis externa 396 10.2 9.1–11.3 11.2 10.0–12.4 6.5 4.7–8.3 0.001
Periodontal disease 361 9.3 8.3–10.3 9.4 8.2–10.5 9.2 7.4–11.0 1.000
Anal sac impaction 277 7.1 6.1–8.1 7.1 6.0–8.1 7.5 5.7–9.4 1.000
Overgrown nails 276 7.1 6.1–8.2 6.9 5.8–8.0 8.0 6.1–9.9 1.000
Degenerative joint disease 256 6.6 5.7–7.5 6.4 5.3–7.4 7.5 5.7–9.4 1.000
Diarrhoea 249 6.4 5.5–7.4 6.8 5.6–8.0 4.9 3.4–6.4 0.255
Obesity 238 6.1 5.2–7.1 6.7 5.6–7.9 3.9 2.3–5.5 0.006
Traumatic injury 214 5.5 4.7–6.4 5.5 4.4–6.5 5.7 3.6–7.7 1.000
Conjunctivitis 192 4.9 4.1–5.8 5.2 4.2–6.2 4.1 2.8–5.5 1.000
Vomiting 159 4.1 3.3–4.9 4.0 3.1–4.9 4.5 3.0–6.0 1.000
Heart murmur 153 3.9 3.3–4.5 4.1 3.5–4.7 3.4 2.1–4.7 1.000
Lipoma 137 3.5 2.8–4.2 3.5 2.7–4.2 3.8 2.7–4.9 1.000
Dermatitis 134 3.5 2.8–4.1 3.5 2.8–4.3 3.1 1.9–4.4 1.000
Skin hypersensitivity 113 2.9 2.3–3.5 3.2 2.5–3.9 1.8 0.9–2.6 0.116
Skin mass 110 2.8 2.3–3.4 3.2 2.6–3.8 1.5 0.6–2.4 0.033
Claw injury 103 2.7 2.1–3.2 2.6 2.0–3.2 2.6 1.5–3.8 1.000
Behavioural 99 2.6 2.1–3.0 2.6 2.1–3.1 2.4 1.4–3.4 1.000
Gastroenteritis 99 2.6 2.0–3.1 2.4 1.9–2.9 3.1 2.0–4.3 1.000
Dog bite injury 97 2.5 1.9–3.1 2.4 1.7–3.1 2.9 1.8–4.0 1.000
Laceration 92 2.4 1.8–2.9 2.5 1.8–3.1 2.0 1.1–2.9 0.446

P-values (Holm-adjusted) represent comparison between purebreds and crossbreds.

a

Prev prevalence.

b

95% CI 95% confidence interval.

Table 3. Prevalence results for frequent disorders recorded in popular breeds (number of dogs) from 3,884 randomly sampled dogs attending primary veterinary practices in England.

Prevalence percentage (95% confidence interval)
Disorder Crossbred (797) Labrador Retriever (339) Staffordshire Bull Terrier (334) Jack Russell Terrier (262) Cocker Spaniel (133) German Shepherd Dog (132) Yorkshire Terrier (127) Border Collie (104) P-Value
Otitis externa 6.5 (4.7–8.3) 11.8 (8.8–15.7) 9.9 (7.1–13.6) 6.9 (4.4–10.6) 8.3 (4.7–14.2) 11.4 (7.0–17.9) 7.9 (4.3–13.9) 1.9 (0.5–6.7) 0.084
Periodontal disease 9.2 (7.4–11.0) 3.2 (1.8–5.7) 2.4 (1.2–4.7) 9.5 (6.6–13.7) 12.8 (8.1–19.5) 4.5 (2.1–9.6) 25.2 (18.6–33.4) 6.7 (3.3–13.3) 0.002
Anal sac impaction 7.5 (5.7–9.4) 4.7 (2.9–7.5) 3.3 (1.9–5.8) 6.9 (4.4–10.6) 12.0 (7.5–18.6) 6.1 (3.1–11.5) 6.3 (3.2–11.9) 2.9 (1.0–8.1) 0.066
Overgrown nails 8.0 (6.1–9.9) 6.5 (4.3–9.6) 3.9 (2.3–6.5) 13.7 (10.1–18.4) 2.3 (0.8–6.4) 1.5 (0.4–5.4) 15.0 (9.8–22.2) 1.0 (0.2–5.3) 0.004
Degenerative joint disease 7.5 (5.9–9.6) 11.5 (8.5–15.3) 5.4 (3.4–8.4) 4.2 (2.4–7.4) 1.5 (0.4–5.3) 6.8 (3.6–12.5) 1.6 (0.4–5.6) 11.5 (6.7–19.1) 0.005
Diarrhoea 4.9 (3.4–6.4) 8.3 (5.8–11.7) 4.8 (3.0–7.6) 4.6 (2.6–7.8) 9.8 (5.8–16.0) 8.3 (4.7–14.3) 5.5 (2.7–10.9) 7.7 (4.0–14.5) 1.000
Obesity 3.9 (2.3–5.5) 13.0 (9.8–17.0) 6.0 (3.9–9.1) 5.3 (3.2–8.8) 8.3 (4.7–14.2) 2.3 (0.8–6.5) 0.8 (0.1–4.3) 6.7 (3.3–13.3) 0.001
Traumatic injury 5.7 (3.6–7.7) 5.3 (3.4–8.2) 4.5 (2.7–7.3) 6.1 (3.8–9.7) 5.3 (2.6–10.5) 4.6 (2.1–9.6) 3.2 (1.2–7.8) 4.8 (2.1–10.8) 1.000
Conjunctivitis 4.1 (2.8–5.5) 4.1 (2.5–6.8) 5.1 (3.2–8.0) 4.2 (2.4–7.4) 6.8 (3.6–12.4) 0.0 (0.0–2.8) 7.1 (3.8–12.9) 4.8 (2.1–10.8) 1.000
Vomiting 4.5 (3.0–6.0) 3.8 (2.3–6.5) 3.9 (2.3–6.5) 5.7 (3.5–9.2) 2.3 (0.8–6.4) 4.6 (2.1–9.6) 3.2 (1.2–7.8) 1.9 (0.5–6.7) 1.000
Heart murmur 3.4 (2.1–4.7) 1.5 (0.6–3.4) 2.7 (1.4–5.0) 3.8 (2.1–6.9) 3.8 (1.6–8.5) 1.5 (0.4–5.4) 7.1 (3.8–12.9) 4.8 (2.1–10.8) 0.837
Lipoma 3.8 (2.7–4.9) 9.1 (6.5–12.7) 2.1 (1.0–4.3) 2.7 (1.3–5.4) 6.0 (3.1–11.4) 1.5 (0.4–5.4) 2.1 (0.0–2.9) 5.8 (2.7–12.0) 0.003
Dermatitis 3.1 (1.9–4.4) 1.5 (0.6–3.4) 3.6 (2.1–6.2) 3.4 (1.8–6.4) 3.0 (1.2–7.5) 3.0 (1.2–7.5) 4.7 (2.2–9.9) 6.7 (3.3–13.3) 1.000
Skin hypersensitivity 1.8 (0.9–2.6) 3.8 (2.3–6.5) 5.1 (3.2–8.0) 3.1 (1.6–5.9) 1.5 (0.4–5.3) 3.0 (1.2–7.5) 3.2 (1.2–7.8) 2.9 (1.0–8.1) 1.000
Skin mass 1.5 (0.6–2.4) 3.2 (1.8–5.7) 3.9 (2.3–6.5) 2.3 (1.1–4.9) 3.8 (1.6–8.5) 3.0 (1.2–7.5) 2.4 (0.8–6.7) 3.0 (1.0– 8.1) 1.000
Claw injury 2.6 (1.5–3.8) 3.8 (2.3–6.5) 3.6 (2.1–6.2) 2.7 (1.3–5.4) 2.3 (0.8–6.4) 3.0 (1.2–7.5) 3.9 (1.7–8.9) 2.9 (1.0–8.1) 1.000
Undesirable behaviour 2.4 (1.4–3.4) 3.0 (1.6–5.3) 2.7 (1.4–5.0) 1.5 (0.6–3.9) 3.0 (1.2–7.5) 7.6 (4.2–13.4) 2.4 (0.8–6.7) 5.8 (2.7–12.0) 0.208
Gastroenteritis 3.1 (2.0–4.3) 4.4 (2.7–7.3) 1.5 (0.6–3.5) 1.9 (0.8–4.4) 3.0 (1.2–7.5) 0.8 (0.1–4.2) 3.9 (1.7–8.9) 3.9 (1.5–9.5) 1.000
Dog bite injury 2.9 (1.8–4.0) 1.5 (0.6–3.4) 3.0 (1.6–5.4) 3.8 (2.1–6.9) 3.8 (1.6–8.5) 1.5 (0.4–5.4) 0.0 (0.0–2.9) 1.0 (0.2–5.3) 1.000
Laceration 2.0 (1.2–3.2) 3.5 (2.0–6.1) 2.4 (1.2–4.7) 2.7 (1.3–5.4) 3.0 (1.2–7.5) 0.8 (0.1–4.2) 1.6 (0.4–5.6) 2.9 (1.0–8.1) 1.000

P-values (Holm-adjusted) represent comparison between breeds.

Within 54 mid-level diagnosis terms, the most prevalent disorders were enteropathic (n = 692, prevalence: 17.8%, 95% CI: 16.0–19.6), dermatological (602, 15.5%, 95% CI: 13.9–17.1), musculoskeletal (457, 11.8%, 95% CI: 10.6–12.9) and aural (426, 11.0%, 95% CI: 9.8–12.2). Purebred dogs showed a significantly higher prevalence than crossbreds for four of the twenty most-prevalent mid-level disorders: dermatological (P = 0.004), aural (P = 0.001), ophthalmological (P = 0.032) and obesity (P = 0.009) (Table 4). Statistically significant differences in prevalence values were shown between the most popular breeds in eight of the twenty most-frequent mid-level disorders: musculoskeletal (P = 0.002), claw/nail (P = 0.008), dental (P = 0.007), neoplastic (P = 0.001), anal sac (P = 0.006), obesity (P = 0.004), cardiac (P = 0.005) and brain (P = 0.003) (Table 5).

Table 4. Prevalence results for the most frequent mid-level disorders recorded in dogs, purebreds only and crossbreds only that attended primary veterinary practices in England.

Overall Purebred Crossbred
Mid-level disorder No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P-value
Enteropathic 692 17.8 16.0–19.6 17.7 15.8–19.7 18.3 15.4–21.2 1.000
Dermatological 602 15.5 13.9–17.1 16.5 14.6–18.4 11.9 10.0–13.9 0.004
Musculoskeletal 457 11.8 10.6–12.9 11.2 9.8–12.6 14.1 11.8–16.3 0.130
Aural 426 11.0 9.8–12.2 12.0 10.7–13.3 7.2 5.3–9.0 0.001
Ophthalmological 406 10.5 9.1–11.8 11.1 9.7–12.6 7.9 6.1–9.7 0.032
Claw/nail 400 10.3 9.1–11.5 10.1 8.8–11.5 10.9 9.0–12.9 1.000
Dental 386 9.9 8.8–11.1 10.0 8.8–11.2 9.8 7.9–11.7 1.000
Neoplastic 367 9.5 8.2–10.7 9.6 8.2–10.9 9.2 7.2–11.1 1.000
Traumatic injury (not incl. bites) 351 9.0 8.0–10.1 9.1 7.8–10.3 8.9 6.6–11.2 1.000
Anal sac 337 8.7 7.5–9.8 8.6 7.3–9.9 9.0 7.1–11.0 1.000
Obesity 238 6.1 5.2–7.1 6.7 5.6–7.9 3.9 2.3–5.5 0.009
Mass lesion 235 6.1 5.2–6.9 6.4 5.3–7.4 4.9 3.4–6.4 0.726
Behavioural 233 6.0 5.3–6.85 5.8 4.9–6.7 6.9 5.1–8.7 1.000
Upper respiratory tract 223 5.7 4.9–6.5 5.6 4.6–6.6 6.4 4.6–8.2 1.000
Cardiac 219 5.6 4.8–6.5 5.9 5.0–6.7 4.9 3.1–6.7 1.000
Parasitic 172 4.4 3.8–5.1 4.2 3.5–5.0 5.3 3.7–6.8 1.000
Congenital 171 4.4 3.7–5.1 4.6 3.7–5.4 3.9 2.6–5.2 1.000
Bite injury 148 3.8 3.0–4.6 3.7 2.9–4.6 4.1 2.8–5.5 1.000
Urinary 126 3.2 2.7–3.8 3.4 2.7–4.1 2.8 1.6–3.9 1.000
Brain 122 3.1 2.5–3.7 3.2 2.6–3.8 3.1 1.9–4.4 1.000

P-values (Holm-adjusted) represent comparison between purebreds and crossbreds.

a

Prev prevalence.

b

95% CI 95% confidence interval.

Table 5. Prevalence results for frequent mid-level disorders recorded in popular breeds (number of dogs) attending primary veterinary practices in England.

Prevalence percentage (95% confidence interval)
Mid-level disorder Crossbred (797) Labrador Retriever (339) Staffordshire Bull Terrier (334) Jack Russell Terrier (262) Cocker Spaniel (133) German Shepherd Dog (132) Yorkshire Terrier (127) Border Collie (104) P-value
Enteropathic 18.3 (15.4–21.2) 22.7 (18.6–27.5) 13.2 (10.0–17.2) 15.3 (11.4–20.1) 18.8 (13.1–26.3) 20.5 (14.5–28.1) 16.5 (11.1–24.0) 17.3 (11.2–25.7) 1.000
Dermatological 11.9 (10.0–13.9) 16.8 (13.2–21.2) 14.7 (11.38–18.9) 13.0 (9.4–17.6) 9.8 (5.8–16.0) 18.9 (13.2–26.5) 18.1 (12.4–25.7) 18.3 (12.0–26.8) 0.715
Musculoskeletal 14.1 (11.8–16.3) 16.2 (12.7–20.5) 8.4 (5.9–11.9) 7.3 (4.7–11.1) 3.0 (1.2–7.5) 16.7 (11.3–24.0) 6.3 (3.2–11.9) 16.4 (10.5–24.6) 0.002
Aural 7.2 (5.3–9.0) 12.1 (9.0–16.0) 11.1 (8.1–14.9) 7.6 (5.0–11.5) 9.0 (5.2–15.1) 11.4 (7.0–17.9) 7.9 (4.3–13.9) 4.8 (2.1–10.8) 0.828
Ophthalmological 7.9 (6.1–9.7) 6.8 (4.6–10.0) 8.1 (5.6–11.5) 8.0 (5.3–11.9) 12.0 (7.5–18.7) 2.3 (0.8–6.5) 12.6 (7.9–19.5) 12.5 (7.5–20.2) 0.261
Claw/nail 10.9 (9.0–12.9) 10.9 (8.0–14.7) 7.5 (5.1–10.8) 14.9 (11.1–19.7) 5.3 (2.6–10.5) 5.3 (2.6–10.5) 19.7 (13.7–27.5) 5.8 (2.7–12.0) 0.008
Dental 9.8 (7.9–11.7) 3.8 (2.3–6.5) 3.0 (1.6–5.4) 11.5 (8.1–15.9) 12.8 (8.1–19.5) 5.3 (2.6–10.5) 25.2 (18.5–33.4) 7.7 (4.0–14.5) 0.007
Neoplastic 9.2 (7.2–11.1) 14.8 (11.4–18.9) 6.6 (4.4–9.8) 4.6 (2.6–7.8) 13.5 (8.7–20.4) 4.6 (2.1–9.6) 6.3 (3.2–11.9) 8.7 (4.6–15.6) 0.001
Traumatic injury (not bites or claw) 8.9 (6.6–11.2) 11.2 (8.3–15.0) 7.88 (5.4–11.2) 9.2 (6.2–13.3) 10.5 (6.4–16.9) 6.1 (3.1–11.5) 3.9 (1.7–8.9) 9.6 (5.3–16.8) 1.000
Anal sac 9.0 (7.1–11.0) 5.9 (3.9–8.9) 3.6 (2.1–6.2) 9.9 (6.9–14.1) 13.5 (8.7–20.4) 6.8 (3.6–12.5) 6.3 (3.2–11.9) 2.9 (1.0–8.1) 0.006
Obesity 3.9 (2.3–5.5) 12.98 (9.81–16.98) 6.0 (3.9–9.1) 5.3 (3.2–8.8) 8.3 (4.7–14.2) 2.3 (0.8–6.5) 0.8 (0.1–4.3) 6.7 (3.3–13.3) 0.004
Mass lesion 4.9 (3.4–6.4) 8.26 (5.78–11.68) 6.6 (4.4–9.8) 5.0 (2.9–8.3) 6.8 (3.6–12.4) 6.1 (3.1–11.5) 7.9 (4.3–13.9) 8.7 (4.6–15.6) 1.000
Behavioural 6.9 (5.1–8.7) 4.7 (2.9–7.5) 5.1 (3.2–8.0) 7.6 (5.0–11.5) 6.8 (3.6–12.4) 12.9 (8.2–19.7) 3.9 (1.7–8.9) 8.7 (4.6–15.6) 0.460
Upper respiratory tract 6.4 (4.6–8.2) 6.2 (4.1–9.3) 6.3 (4.2–9.4) 5.7 (3.5–9.2) 2.3 (0.8–6.4) 3.0 (1.2–7.5) 7.1 (3.8–12.9) 2.9 (1.0–8.1) 1.000
Cardiac disorder 4.9 (3.1–6.7) 1.5 (0.6–3.4) 3.0 (1.6–5.4) 6.5 (4.1–10.1) 4.5 (2.1–9.5) 1.5 (0.4–5.4) 10.2 (6.1–16.7) 5.8 (2.7–12.0) 0.005
Parasitic 5.3 (3.7–6.8) 3.5 (2.0–6.1) 4.8 (3.0–7.6) 3.4 (1.8–6.4) 8.3 (4.7–14.2) 2.3 (0.8–6.5) 4.7 (2.2–9.9) 1.9 (0.5–6.7) 1.000
Congenital 3.9 (2.6–5.2) 2.4 (1.2–4.6) 2.1 (1.0–4.3) 3.8 (2.2–6.9) 3.8 (1.6–8.5) 0.8 (0.1–4.2) 6.3 (3.2–11.9) 1.9 (0.5–6.7) 1.000
Bite injury 4.1 (2.8–5.5) 3.8 (2.3–6.5) 4.29 (2.5–6.9) 5.0 (2.9–8.3) 4.5 (2.1–9.5) 2.3 (0.8–6.5) 1.6 (0.4–5.6) 1.9 (0.5–6.7) 1.000
Urinary 2.8 (1.6–3.9) 4.7 (2.9–7.5) 2.4 (1.2–4.6) 1.9 (0.8–4.4) 3.0 (1.2–7.5) 3.0 (1.2–7.5) 2.4 (0.8–6.7) 3.9 (1.5–9.5) 1.000
Brain 3.1 (1.9–4.4) 3.2 (1.8–5.7) 0.6 (0.2–2.2) 2.3 (1.1–4.9) 3.0 (1.2–7.5) 4.6 (2.1–9.6) 1.6 (0.4–5.6) 9.6 (5.3–16.8) 0.003

P–values (Holm–adjusted) represent comparison between breeds. (n = 3,884).

Syndromic classification analysis indicated that the most prevalent body locations affected in dogs were the head-and-neck (n = 1,273, prevalence = 32.8%, 95% CI: 30.7–34.9), abdomen (993, 25.6%, 95% CI: 23.6–27.5) and limb (679, 17.5%, 95% C: 15.9–19.1). Purebreds had significantly higher prevalence values compared with crossbreds for two of the eight body locations: head-and-neck (P = 0.003) and tail (P = 0.038) disorders. The most prevalent organ systems affected were the integument (1,408, 36.3%, 95% CI: 33.9–38.6), digestive (1,144, 29.5%, 95% CI: 27.5–31.5) and musculoskeletal (573, 14.8%, 95% CI: 13.8–16.0) (Table 6). Purebreds had significantly higher prevalence values than crossbreds for two of fifteen organ systems, namely integument (P = 0.001) and auditory (P = 0.002) (Table 6). The most prevalent pathophysiologic processes recorded were inflammation (1,246, 32.1%, 95% CI: 29.8–34.3), mass/swelling (625, 16.1%, 95% CI: 14.6–17.6) and traumatic (557, 14.3%, 95% CI: 12.8–15.9). Purebreds had significantly higher prevalence values than crossbreds for two of twenty-one pathophysiological processes: inflammatory (P = 0.006) and nutritional (P = 0.0014) disorders (Table 7). Statistically significant differences in prevalence values between the most popular breeds were shown for 5/8 body location terms, 5/15 organ system terms and 5/21 pathophysiologic processes (Tables 8, 9 &10).

Table 6. Prevalence of syndromic disorders affecting body location and organ system recorded in overall dogs, purebreds only and crossbreds only that attended primary veterinary practices in England.

Overall Purebred Crossbred
No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P–value
Body Location
Head/neck 1,273 32.8 30.7–34.9 34.0 31.7–36.2 28.5 24.9–32.0 0.003
Abdomen 993 25.6 23.6–27.5 25.9 23.7–28.0 24.6 21.5–27.7 1.000
Limb 679 17.5 15.9–19.1 17.3 15.5–19.1 18.3 15.7–20.9 1.000
Anus/perineum 359 9.2 8.1–10.4 9.1 7.8–10.5 9.8 7.6–12.0 1.000
Thorax 353 9.1 8.1–10.1 9.2 8.1–10.4 8.7 6.5–10.8 1.000
Vertebral column 78 2.0 1.5–2.5 2.0 1.5–2.6 2.0 1.0–3.0 1.000
Pelvis 33 0.9 0.6–1.2 0.9 0.7–1.4 0.5 0.2–1.3 0.684
Tail 21 0.5 0.4–0.8 0.7 0.5–1.0 0.0 0.0–0.5 0.038
Organ system
Integument 1,408 36.3 33.9–38.6 37.6 35.0–40.2 31.4 28.0–34.7 0.001
Digestive 1,144 29.5 27.5–31.5 29.4 27.2–31.6 30.0 26.6–33.3 1.000
Musculoskeletal 573 14.8 13.5–16.0 14.1 12.6–15.6 17.3 14.8–19.8 0.110
Connective/Soft tissue 503 13.0 11.6–14.3 13.2 11.6–14.7 12.3 10.2–14.4 1.000
Ocular 447 11.5 10.2–12.8 12.2 10.6–13.7 9.2 7.2–11.1 0.057
Auditory 437 11.3 10.0–12.5 12.3 11.0–13.6 7.4 5.5–9.3 0.002
Nervous 301 7.8 6.8–8.7 7.7 6.7–8.7 7.9 6.2–9.6 1.000
Respiratory 273 7.0 6.2–7.9 7.0 6.0–8.1 7.2 5.2–9.1 1.000
Cardiovascular 241 6.2 5.3–7.1 6.5 5.5–7.4 5.3 3.5–7.1 1.000
Urinary 227 5.8 5.1–6.6 5.9 4.9–6.8 5.8 4.1–7.5 1.000
Reproductive 184 4.7 4.1–5.4 4.7 4.0–5.5 4.9 3.5–6.3 1.000
Endocrine 72 1.9 1.5–2.3 1.8 1.3–2.3 2.1 1.2–3.1 1.000
Haematopoietic 53 1.4 1.0–1.7 1.4 1.0–1.8 1.3 0.5–2.1 1.000
Hepatobiliary 29 0.8 0.5–1.1 0.9 0.6–1.3 0.1 0.0–0.7 0.088
Lymphatic 26 0.7 0.5–1.0 0.6 0.4–1.0 0.9 0.4–1.8 1.000

P–values (Holm–adjusted) represent comparison between purebreds and crossbreds.

a

Prev prevalence.

b

95% CI 95% confidence interval.

Table 7. Prevalence of syndromic disorders related to pathophysiologic processes recorded in overall dogs, purebreds only and crossbreds only that attended primary veterinary practices in England.

Overall Purebred Crossbred
Pathophysiologic process No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P–value
Inflammation 1,246 32.1 29.8–34.3 33.2 30.7–35.7 28.1 25.1–31.2 0.006
Mass/swelling 625 16.1 14.6–17.6 16.7 15.0–18.4 14.1 11.8–16.3 0.222
Traumatic 557 14.3 12.8–15.9 14.3 12.7–16.0 14.3 11.6–17.0 1.000
Degenerative 411 10.6 9.4–11.8 10.4 9.0–11.7 11.4 9.1–13.8 1.000
Infectious 388 10.0 9.0–11.0 10.3 9.1–11.4 9.0 6.9–11.2 1.000
Neoplastic 336 8.7 7.6–9.8 8.6 7.3–9.8 9.0 7.2–10.9 1.000
Congenital/developmental 332 8.6 7.4–9.7 8.9 7.6–10.2 7.3 5.6–9.2 0.870
Nutritional 320 8.2 7.1–9.4 8.9 7.5–10.2 5.9 4.3–7.5 0.014
Behavioural 262 6.8 5.9–7.6 6.5 5.5–7.4 7.9 6.0–9.8 1.000
Hereditary 232 6.0 5.1–6.9 6.2 5.1–7.3 5.3 3.5–7.0 1.000
Parasitic 221 5.7 5.0–6.4 5.5 4.6–6.3 6.7 5.0–8.4 1.000
Iatrogenic 150 3.9 3.3–4.5 3.7 3.1–4.4 4.4 2.9–5.9 1.000
Foreign body 109 2.8 2.3–3.3 2.8 2.3–3.4 2.8 1.6–3.9 1.000
Death 65 1.7 1.2–2.2 1.6 1.1–2.1 2.1 1.2–3.1 1.000
Intoxicative 49 1.3 1.0–1.7 1.3 1.0–1.8 1.1 0.6–2.1 1.000
Haemostatic 38 1.0 0.7–1.3 1.1 0.8–1.5 0.5 0.2–1.3 0.496
Immune–mediated 38 1.0 0.7–1.3 1.1 0.8–1.5 0.5 0.2–1.3 0.620
Allergic 35 0.9 0.7–1.3 0.9 0.6–1.3 0.9 0.4–1.8 1.000
Thermoregulatory 17 0.4 0.3–0.7 0.4 0.2–0.7 0.6 0.3–1.5 1.000
Metabolic 8 0.2 0.1–0.4 0.2 0.1–0.4 0.3 0.1–0.9 1.000
Effusion 1 0.0 0.0–0.2 0.0 0.0–0.2 0.0 0.0–0.5 1.000

P–values (Holm–adjusted) represent comparison between purebreds and crossbreds.

a

Prev prevalence.

b

95% CI 95% confidence interval.

Table 8. Prevalence of syndromic diagnoses affecting body location recorded in crossbred dogs and popular breeds (number of dogs) from 3,884 randomly sampled dogs attending primary veterinary practices in England.

Prevalence percentage (95% confidence interval)
Body Location Crossbred (797) Labrador Retriever (339) Staffordshire Bull Terrier (334) Jack Russell Terrier (262) Cocker Spaniel (133) German Shepherd Dog (132) Yorkshire Terrier (127) Border Collie (104) P–Value
Head/neck 28.5 (24.9–32.0) 28.6 (24.1–33.6) 24.0 (19.7–28.8) 30.5 (25.3–36.4) 33.1 (25.7–41.5) 22.7 (16.4–30.6) 43.3 (35.0–52.0) 35.6 (27.0–45.1) 0.006
Abdomen 24.6 (21.5–27.7) 32.4 (27.7–37.6) 21.0 (16.9–25.6) 21.0 (16.5–26.3) 27.1 (20.2–35.2) 25.8 (19.1–33.8) 20.5 (14.4–28.3) 30.8 (22.7–40.2) 0.045
Limb 18.3 (15.7–20.9) 20.4 (16.4–25.0) 14.1 (10.7–18.2) 20.2 (15.8–25.5) 7.5 (4.1–13.3) 13.6 (8.8–20.5) 22.0 (15.7–30.0) 16.3 (10.5–24.6) 0.036
Anus/perineum 9.8 (7.6–12.0) 6.2 (4.1–9.3) 3.9 (2.3–6.5) 9.9 (6.9–14.1) 15.0 (10.0–22.1) 9.1 (5.3–15.2) 7.1 (3.8–12.9) 3.8 (1.5–9.5) 0.001
Thorax 8.7 (6.5–10.8) 6.5 (4.3–9.6) 6.0 (3.9–9.1) 8.8 (5.9–12.8) 6.0 (3.1–11.4) 3.0 (1.2–7.5) 13.4 (8.5–20.4) 6.7 (3.3–13.2) 0.294
Vertebral column 2.0 (1.0–3.0) 1.5 (0.6–3.4) 0.3 (0.1–1.7) 1.1 (0.4–3.3) 3.8 (1.6–8.5) 1.5 (0.4–5.4) 0.8 (0.1–4.3) 2.9 (1.0–8.1) 1.000
Pelvis 0.5 (0.2–1.3) 0.6 (0.2–2.1) 0.6 (0.2–2.2) 0.0 (0.0–1.4) 0.0 (0.0–2.8) 0.0 (0.0–2.8) 1.6 (0.4–5.6) 1.0 (0.2–5.2) 1.000
Tail 0.0 (0.0–0.5) 2.4 (1.2–4.6) 0.3 (0.1–1.7) 0.0 (0.0–1.4) 1.5 (0.4–5.3) 0.0 (0.0–2.8) 0.0 (0.0–2.9) 1.0 (0.2–5.2) 0.002

P–values (Holm–adjusted) represent comparison between breeds.

Table 9. Prevalence of syndromic diagnoses affecting organ system recorded in crossbred dogs and popular breeds (number of dogs) from 3,884 randomly sampled dogs attending primary veterinary practices in England.

Prevalence percentage (95% confidence interval)
Organ system Crossbred (797) Labrador Retriever (339) Staffordshire Bull Terrier (334) Jack Russell Terrier (262) Cocker Spaniel (133) German Shepherd Dog (132) Yorkshire Terrier (127) Border Collie (104) P–Value
Integument 31.4 (28.0–34.7) 39.2 (34.2–44.5) 36.2 (31.3–41.5) 34.0 (28.5–39.9) 33.8 (26.3–42.2) 34.8 (27.3–43.3) 42.5 (34.3–51.2) 29.8 (21.9–39.2) 0.816
Digestive 30.0 (26.6–33.3) 29.8 (25.2–34.9) 19.2 (15.3–23.7) 28.6 (23.5–34.4) 36.1 (28.4–44.5) 27.3 (20.4–35.4) 44.1 (35.8–52.8) 26.9 (19.3–36.2) 0.002
Musculoskeletal 17.3 (14.8–19.8) 19.2 (15.3–23.7) 9.6 (6.9–13.2) 9.5 (6.5–13.7) 6.8 (3.6–12.4) 18.9 (13.2–26.5) 8.7 (4.9–14.8) 22.1 (15.2–31.0) 0.005
Connective/Soft tissue 12.3 (10.2–14.4) 16.2 (12.7–20.5) 9.9 (7.1–13.6) 9.5 (6.5–13.7) 14.3 (9.3–21.2) 5.3 (2.6–10.5) 9.4 (5.5–15.8) 17.3 (11.2–25.7) 0.060
Ocular 9.2 (7.2–11.1) 9.1 (6.5–12.7) 8.7 (6.1–12.2) 8.8 (5.9–12.8) 12.8 (8.1–19.5) 2.3 (0.8–6.5) 13.4 (8.5–20.4) 14.4 (8.9–22.4) 0.203
Auditory 7.4 (5.5–9.3) 12.4 (9.3–16.3) 11.1 (8.1–14.9) 8.4 (5.6–12.4) 10.5 (6.4–16.9) 11.4 (7.0–17.9) 7.9 (4.3–13.9) 5.8 (2.7–12.0) 1.000
Nervous 7.9 (6.2–9.6) 8.3 (5.8–11.7) 3.0 (1.6–5.4) 5.7 (3.5–9.2) 9.0 (5.2–15.1) 12.9 (8.2–19.7) 3.1 (1.2–7.8) 15.4 (9.7–23.5) 0.003
Respiratory 7.2 (5.2–9.1) 8.0 (5.5–11.3) 6.9 (4.6–10.1) 7.3 (4.7–11.0) 3.0 (1.2–7.5) 3.8 (1.6–8.6) 8.7 (4.9–14.8) 3.8 (1.5–9.5) 1.000
Cardiovascular 5.3 (3.5–7.1) 1.5 (0.6–3.4) 3.3 (1.8–5.8) 7.6 (5.0–11.5) 5.3 (2.6–10.5) 1.5 (0.4–5.4) 11.0 (6.7–17.7) 6.7 (3.3–13.2) 0.001
Urinary 5.8 (4.1–7.5) 5.3 (3.4–8.2) 3.6 (2.1–6.2) 4.6 (2.6–7.8) 6.8 (3.6–12.4) 4.5 (2.1–9.6) 6.3 (3.2–11.9) 6.7 (3.3–13.2) 1.000
Reproductive 4.9 (3.5–6.3) 2.7 (1.4–5.0) 6.0 (3.9–9.1) 5.0 (2.9–8.3) 5.3 (2.6–10.5) 2.3 (0.8–6.5) 3.9 (1.7–8.9) 1.0 (0.2–5.2) 1.000
Endocrine 2.1 (1.2–3.1) 1.5 (0.6–3.4) 1.2 (0.5–3.0) 2.3 (1.1–4.9) 0.0 (0.0–2.8) 0.8 (0.1–4.2) 2.4 (0.8–6.7) 1.9 (0.5–6.7) 1.000
Haematopoietic 1.3 (0.7–2.3) 2.1 (1.0–4.2) 1.2 (0.5–3.0) 0.4 (0.1–2.1) 1.5 (0.4–5.3) 1.5 (0.4–5.4) 0.0 (0.0–2.9) 0.0 (0.0–3.6) 1.000
Hepatobiliary 0.1 (0.0–0.7) 1.8 (0.8–3.8) 0.0 (0.0–1.1) 0.4 (0.1–2.1) 0.0 (0.0–2.8) 0.0 (0.0–2.8) 0.0 (0.0–2.9) 3.8 (1.5–9.5) 0.004
Lymphatic 0.9 (0.4–1.8) 0.6 (0.2–2.1) 0.6 (0.2–2.2) 0.4 (0.1–2.1) 0.8 (0.1–4.1) 0.0 (0.0–2.8) 0.0 (0.0–2.9) 1.0 (0.2–5.2) 1.000

P–values (Holm–adjusted) represent comparison between breeds.

Table 10. Prevalence of syndromic diagnoses relating to pathophysiologic processes recorded in crossbred and popular breeds (number of dogs) attending primary veterinary practices in England.

Prevalence percentage (95% confidence interval)
Pathophysiologic process Crossbred (797) Labrador Retriever (339) Staffordshire Bull Terrier (334) Jack Russell Terrier (262) Cocker Spaniel (133) German Shepherd Dog (132) Yorkshire Terrier (127) Border Collie (104) P–Value
Inflammation 28.1 (25.1–31.2) 37.8 (32.8–43.0) 29.6 (25.0–34.7) 25.2 (20.3–30.8) 27.8 (20.9–36.0) 32.6 (25.2–41.0) 35.4 (27.7–44.1) 27.9 (20.2–37.2) 0.120
Mass/swelling 14.1 (11.8–16.3) 23.3 (19.1–28.1) 14.1 (10.7–18.2) 11.1 (7.8–15.4) 20.3 (14.3–27.9) 12.1 (7.6–18.8) 14.2 (9.2–21.3) 24.0 (16.8–33.1) 0.004
Traumatic 14.3 (11.6–17.0) 18.3 (14.5–22.8) 14.1 (10.7–18.2) 14.5 (10.8–19.3) 16.5 (11.2–23.8) 11.4 (7.0–17.9) 7.1 (3.8–12.9) 15.4 (9.7–23.5) 1.000
Degenerative 11.4 (9.1–13.8) 15.6 (12.2–19.9) 7.5 (5.1–10.8) 7.6 (5.0–11.5) 4.5 (2.1–9.5) 9.8 (5.8–16.1) 6.3 (3.2–11.9) 18.3 (12.0–26.8) 0.001
Infectious 9.0 (6.9–11.2) 13.9 (10.6–17.9) 7.8 (5.4–11.2) 8.0 (5.3–11.9) 9.0 (5.2–15.1) 10.6 (6.4–17.0) 7.9 (4.3–13.9) 13.5 (8.2–21.3) 0.990
Neoplastic 9.0 (7.2–10.9) 15.3 (11.9–19.6) 6.3 (4.1–9.4) 4.6 (2.6–7.8) 12.8 (8.1–19.5) 2.3 (0.8–6.5) 3.9 (1.7–8.9) 9.6 (5.3–16.8) 0.003
Congenital 7.3 (5.6–9.2) 5.0 (3.2–7.9) 4.8 (3.0–7.6) 6.5 (4.1–10.1) 7.5 (4.1–13.3) 6.1 (3.1–11.5) 11.0 (6.7–17.7) 5.8 (2.7–12) 1.000
Nutritional 5.9 (4.3–7.5) 16.5 (12.9–20.8) 7.5 (5.1–10.8) 6.9 (4.4–10.6) 9.8 (5.8–16.0) 3.8 (1.6–8.6) 2.4 (0.8–6.7) 9.6 (5.3–16.8) 0.002
Behavioural 7.9 (6.0–9.8) 5.0 (3.2–7.9) 6.6 (4.4–9.8) 8.8 (5.9–12.8) 6.8 (3.6–12.4) 13.6 (8.8–20.5) 3.9 (1.7–8.9) 8.7 (4.6–15.6) 0.400
Hereditary 5.3 (3.5–7.0) 4.4 (2.7–7.2) 3.3 (1.8–5.8) 3.4 (1.8–6.4) 3.0 (1.2–7.5) 7.6 (4.2–13.4) 11.8 (7.3–18.6) 2.9 (1.0–8.1) 0.025
Parasitic 6.7 (5.0–8.4) 6.2 (4.1–9.3) 5.7 (3.7–8.7) 5.0 (2.9–8.3) 9.8 (5.8–16.0) 3.0 (1.2–7.5) 5.5 (2.7–10.9) 2.9 (1.0–8.1) 1.000
Iatrogenic 4.4 (2.9–5.9) 4.4 (2.7–7.2) 3.0 (1.6–5.4) 4.2 (2.4–7.4) 3.8 (1.6–8.5) 4.5 (2.1–9.6) 4.7 (2.2–9.9) 4.8 (2.1–10.8) 1.000
Foreign body 2.8 (1.6–3.9) 3.2 (1.8–5.7) 1.2 (0.5–3.0) 2.7 (1.3–5.4) 2.3 (0.8–6.4) 2.3 (0.8–6.5) 0.0 (0.0–2.9) 3.8 (1.5–9.5) 1.000
Death 2.1 (1.2–3.1) 1.8 (0.8–3.8) 1.5 (0.6–3.5) 0.8 (0.2–2.7) 0.8 (0.1–4.1) 2.3 (0.8–6.5) 3.1 (1.2–7.8) 4.8 (2.1–10.8) 1.000
Intoxicative 1.1 (0.6–2.1) 1.5 (0.6–3.4) 0.9 (0.3–2.6) 1.5 (0.6–3.9) 0.8 (0.1–4.1) 0.0 (0.0–2.8) 1.6 (0.4–5.6) 1.0 (0.2–5.2) 1.000
Haemostatic 0.5 (0.2–1.3) 1.5 (0.6–3.4) 1.8 (0.8–3.9) 1.1 (0.4–3.3) 0.0 (0.0–2.8) 0.8 (0.1–4.2) 0.0 (0.0–2.9) 2.9 (1.0–8.1) 1.000
Immune–mediated 0.5 (0.2–1.3) 0.0 (0.0–1.1) 0.3 (0.1–1.7) 0.8 (0.2–2.7) 2.3 (0.8–6.4) 0.0 (0.0–2.8) 2.4 (0.8–6.7) 1.0 (0.2–5.2) 0.189
Allergic 0.9 (0.4–1.8) 2.1 (1.0–4.2) 0.6 (0.2–2.2) 0.8 (0.2–2.7) 0.8 (0.1–4.1) 0.8 (0.1–4.2) 1.6 (0.4–5.6) 0.0 (0.0–3.6) 1.000
Thermoregulatory 0.6 (0.3–1.5) 0.0 (0.0–1.1) 0.6 (0.2–2.2) 0.8 (0.2–2.7) 0.8 (0.1–4.1) 0.0 (0.0–2.8) 1.6 (0.4–5.6) 1.0 (0.2–5.2) 1.000
Metabolic 0.3 (0.1–0.9) 0.0 (0.0–1.1) 0.0 (0.0–1.1) 0.0 (0.0–1.4) 0.8 (0.1–4.1) 0.0 (0.0–2.8) 0.0 (0.0–2.9) 0.0 (0.0–3.6) 1.000
Effusion 0.0 (0.0–0.5) 0.0 (0.0–1.1) 0.0 (0.0–1.1) 0.0 (0.0–1.4) 0.0 (0.0–2.8) 0.0 (0.0–2.8) 0.0 (0.0–2.9) 0.0 (0.0–3.6) 1.000

P–values (Holm–adjusted) represent comparison between breeds.

Discussion

This study reported the most prevalent disorders recorded in dogs attending primary-care veterinary practices in England as otitis externa, periodontal disease and anal sac impaction, while the most prevalent disorder groups were enteropathic, dermatological and musculoskeletal. The head-and-neck was the most prevalent body location affected, the integument was the most prevalent organ system affected, and inflammation was the most prevalent pathophysiologic process. Some evidence was shown to support higher disorder prevalence in purebred dogs compared with crossbred dogs and for important differences in disorder prevalence between breeds.

The current study was designed to fill a critical data gap relating to disorder prevalence information that has been identified as a constraint to improving dog welfare by effective reform of purebred dog-breeding [20], [21], [22]. Unacceptably high occurrence of inherited disorders in purebred dogs has been discussed since over half a century ago [41], [42], [43], [44], leading to implementation of disease control measures such as defined health schemes [45], [46], [47], [48] and revised KC recommendations and rules for registration and showing [44], [49]. However, the current state and predicted trajectory of purebred dog health remain contentious despite these and other ongoing health measures, suggesting that these earlier breeding reforms that were developed without access to prioritisation information on the overall disorder burden may at best have been sub-optimal, and potentially even counter-productive [50].

Primary-care veterinary clinical data have been proposed as a superior data resource for clinical research in dogs [12], [20]. Although useful, alternative data sources including referral practice data [51], [52], [53], pet insurance databases [27], official health schemes [54], [55], [56] and large scale questionnaire surveys [26], [57], [58], [59] are reported to suffer many limitations for the generation of prevalence values that can be generalised to the wider dog population. Analyses based on primary-care veterinary EPR data benefit from open-ended data collection allowing generation of stronger evidence from cohort compared with cross-sectional study designs [60], [61], [62]. Selection bias is reduced by merging data collected from a miscellany of practices [63] and recall and misclassification biases are reduced by collection of clinical notes recorded contemporaneously by veterinary clinicians during episodes of care [64]. Veterinary primary-care denominator populations are well-characterised demographically within PMSs and include all practice-attending animals, whether presenting healthy or sick, linked with comprehensive clinical documentation that facilitates internal validation [27]. Registration databases from primary-care practices are more representative of the national dog population than other databases available for research purposes; 77% of UK dogs are registered with a veterinary practice compared with just 42% of UK dogs that are insured and 31% of UK dogs that are registered with the KC [2].

Previous large-scale studies using primary-care practice clinical data have been variably successful and have encountered problems with sustainability. A cross-sectional study of paper-based clinical records for 7,146 dogs from eight UK practices described demographic and morbidity results but concluded that direct electronic extraction of clinical data and implementation of standardised coding for breeds and disorders were required to sustain long-term data collection [65]. In the US, the National Companion Animal Study (NCAS) reported overall disorder prevalence values using electronic records from 86,772 dogs attending 63 private practices. However, prevalence estimation was based only on the 36% of animals that had at least one coded disorder term recorded and the full clinical notes were not accessible for case-finding and internal validation exercises [66]. The National Companion Animal Surveillance System (NCASP) was established using EPR data from over 500 Banfield Pet Hospitals, but this system focused on the threat of emerging infection, terrorist attack or natural disaster rather than disorder prevalence [67] and has since been discontinued [68].

A standardised veterinary lexicon is critical for large-scale epidemiological application of secondary clinical data [52], [65], [69], [70]. The VeNom codes [30] offers an open-access veterinary nomenclature that has been developed collaboratively between university and primary-care practice groups and facilitates both direct coding by attending clinicians at the point of clinical care and also retrospective coding by researchers during analysis. The VeNom coding ontology that is made available for point-of-care coding defines multiple clinical fields including species (45 terms), dog breeds (767), cat breeds (101), presenting complaints (201), diagnostic tests (39), diagnoses (2,291) and procedures (780).

The current study indicated that otitis externa (10.2%), periodontal disease (9.3%), anal sac impaction (7.1%) and overgrown nails (7.1%) were the most prevalent disorders recorded in dogs attending veterinary practices in England. A US primary-care study similarly identified dental calculus (20.5%), gingivitis (19.5) and otitis externa (13.0%) as the most prevalent diagnoses in dogs, but reported the prevalence of anal sac disease at only 2.5%, and did not even include nail disorders within the common disorders diagnosed [70]. An under-developed coding system, inconsistent case definitions and selection bias from inclusion of only the one-third of animals that had at least one coded diagnosis term within the US study may explain these differing prevalence trends and underscores the importance of standardised coding systems for reliable comparisons between studies. The high frequency of dental disease reported in the US study may have resulted from inclusion of animals with any recorded dental abnormality, regardless of severity. By contract, the current study aimed to report the occurrence of dental disorders that currently warranted treatment in the opinion of the attending clinician. Study-inclusion of dental abnormalities of any nature provides information on the summative effects from both current and potential future clinically-significant dental disease whereas including just current clinically-significant cases provides evidence on the current welfare implications of dental disease. Both approaches have merit and add to our understanding of the substantial clinical relevance of dental disorders to the health and welfare of dogs. A UK primary-care study using paper-based clinical records identified the most prevalent disorders of dogs as overgrown nails (2.7%), ascarid worm problems (2.3%), anal sac impaction (2.1%), dental calculus (1.8%), fleas (1.8%), bacterial otitis externa (1.7%), waxy otitis externa (1.2%), diarrhoea/vomiting (1.0%) and Otodectes otitis externa (0.9%) [65]. Although the predominance of aural, nail, anal sac and dental disorders identified was consistent with the current study, the older study reported prevalence per consultation values, leading to apparently lower prevalence values than the current study that reported period prevalence per dog. The substantially lower prevalence of parasitic disorders reported in the current study may also reflect increasing adoption and effectiveness of prophylactic parasiticides in the intervening fifteen years since the previous study [71], [72].

Although diagnosis-level disorder terms are useful to describe disorders at their precision of clinical diagnosis, sole reliance on these terms for research may mask important underlying disorder concepts because of fragmentation into multiple terms along diagnostic pathways. The current study grouped clinically-related diagnosis-level terms (430 unique terms) into appropriate, composite mid-level disorder terms (54 unique terms) for further analysis. Selection of cut-off points for amalgamation along diagnostic precision pathways aimed to optimise interpretability whilst still retaining adequate precision [73]. The predominant mid-level disorders (enteropathic, dermatological, musculoskeletal and aural) differed from the predominant diagnosis-level disorders (otitis externa, periodontal disease, anal sac impaction, overgrown nails), suggesting that such hierarchical analysis can offer useful insights that may otherwise be missed.

Syndromic surveillance is based on clinical features that are discernible even from early presentation and are not dependent on complete or even correct diagnosis for elucidation of diagnostic patterns [74]. Although veterinary clinical diagnostic accuracy may have improved over recent years, diagnostic discrepancies have been identified in 15% of cases undergoing necropsy [75]. Syndromic surveillance has been applied within human bioterrorism surveillance [76] and for analysis of canine insurance data [77], [78]. The three syndromic classification systems used in the current study (body location, organ system and pathophysiology) were selected for their potential welfare importance via breed conformation and genetic effects [15]. The syndromic coding system used in the current study was adapted from VeNom codes and other published veterinary lexicons in line with the disorder types recorded within the study [25], [79]. Progression towards a standardised syndromic terminology would facilitate future inter-study comparisons and meta-analyses [80].

The results from syndromic analyses in the current study identified the most prevalent body locations affected by disorders in dogs as the head-and-neck (32.8%), abdomen (25.6%) and limb (17.5%). Morphologic diversity between breeds resulting from artificial selection towards the extremes of breed standard morphometrics [81] has been associated with conformational predisposition for disorders [15], [20]. The predominance of disorders identified affecting the head-and-neck reaffirm the importance of this body area to dog health [82].

The most affected organ systems identified by the current study were the integument (36.3%), digestive (29.5%) and musculoskeletal (14.8%). Swedish insurance data analysis similarly identified the most prevalently affected organs systems as the integument (3.2%), gastrointestinal (2.7%) and genital (2.5%) [83]. A consistently high prevalence reported by these studies for disorders affecting the integument and digestive systems suggests the importance of clinical emphasis on maintaining the health of these systems.

The current study identified inflammation (32.1%), mass/swelling (16.1%) and trauma (14.3%) as the most prevalent pathophysiologic processes affecting dogs. Similarly, a Swedish insurance study identified inflammation (5.4%), symptomatic (3.0%), trauma (2.7%) and neoplasia (2.1%) as the pathological processes with the highest risk of morbidity [83]. Although an essential adaptive response to injury, inflammation can behave both physiologically (restoring homeostasis) and pathologically (contributing to ongoing disease) [84]. The preponderance of inflammatory disorders affecting dogs identified by the current study suggests welfare gains from increased awareness by owners of judicious use of anti-inflammatory medications and also the value from ongoing research to better harness the healing aspects of inflammation while limiting detrimental effects [85].

The current study hypothesised that purebred dogs have higher prevalence of common disorders compared with crossbreds. This hypothesis was founded on reports and studies that concluded substantial detriment to purebred dog welfare from increasing inherited health problems induced by inbreeding and selection for extreme morphologies [15], [16], [20], [21], [22]. The study hypothesis was tested by comparing prevalence values between purebreds and crossbreds for each of the twenty most prevalent diagnosis-level and mid-level disorders and for all syndromic presentations. Purebreds showed significantly higher prevalence values for 13 of the 84 (15.5%) disorders and syndromes evaluated. No instances were identified in which prevalence values were significantly higher in crossbred than in purebred dogs. These results provided moderate evidence for higher disorder prevalence in purebreds compared with crossbreds. However, additional analyses of severity and duration data for these disorders would enable a more comprehensive understanding of health disparities between the groups [23].

Failure to show overwhelming evidence for disorder disparity between purebred and crossbred dogs appears initially at odds with the large body of literature apparently to the contrary [20], [21], [22], [86], [87]. There are a number of possibilities for this dissonance. Breed-specific conformational disorders within purebreds may be under-reported or under-recognised by both veterinarians and owners because ‘normal for breed’ may have become confused with ‘normal’ [88]. A study of dogs clinically diagnosed with brachycephalic obstructive airway syndrome (BOAS) identified that 58% of owners reported these dogs not to have ‘breathing problems’ [82]. Purebred and crossbred dog categories comprise heterogeneous mosaics of size, shape and genetics. Merging this variation into single categories may have masked important effects related to specific conformational, physiological or behavioural features. Analyses of purebred or crossbred subgroups based on breed, behaviour or body attributes may better elucidate important health hazards, benefits and associations.

Purebred dogs comprise 75-80% of the overall UK dog population [3], [28], suggesting that a high proportion of crossbreds are likely to be first or second filial offspring from purebred progenitors and could be reasonably expected to show conformational and polygenic disorder occurrence at the midpoint between the values for their parent breeds, with any additional health benefits in crossbreds resulting from hybrid vigour effects [89]. From this perspective, the less-than-overwhelming evidence provided by the current study for substantially lower prevalence values in crossbred compared with purebred dogs does not refute claims in the literature of rising prevalence values for inherited disorders within purebred dogs. Instead, this suggests that the overall disorder burden within crossbred dogs may reflect the overall disorder burden in purebreds at any point in time. For optimal understanding, disorder prevalence in purebreds should be quantified by analysing cohort health data to identify trends over time.

The most prevalent disorders identified in dogs within the current study were complex disorders that have multiple interacting environmental and genetic casual factors [90]: otitis externa [91], periodontal disease [92], anal sac disorders [93], nail disorders [94], [95], degenerative joint disease [96], diarrhoea [97], [98], obesity [99], traumatic injury [100], conjunctivitis [101], vomiting [101], [102] and heart murmur [103], [104]. It may be useful for canine health research to move away from viewing individual disorders as necessarily either inherited or non-inherited [105] and towards an acknowledgement of relevant roles for both genetic and environmental components in the majority of canine disorders [106], [107], [108]. This acceptance will improve decision-making on effective disease-control and breeding programs [109]. Application of estimated breeding values (EBVs) developed from summative health information derived from a range of sources, including health schemes and veterinary primary-care data, could contribute integrally to novel disorder-control programs [14], [110], [111].

A large body of literature supports the existence of disorder predispositions affecting most dog breeds [15], [16], [112]. Despite inclusion of just seven breeds in the current analysis, breed associations were identified for 33.3% (28/84) of the disorders and syndromes evaluated (diagnosis-level disorders 20% (5/20), mid-level disorders 40% (8/20) and syndromic terms 34% (15/44)). The high-risk breeds differed considerably between the disorders in the current study, suggesting that rational health control measures should focus on highly-predisposed disorders within at-risk breeds. Future breed-specific studies are recommended to report more precise prevalence estimates and for a wider range of breeds. Early studies could focus on the fourteen high-profile breeds identified by the KC as having higher health risks, mainly due to conformational problems [113].

There were some limitations to the current study. The practices participating in the study formed a single veterinary group that extended across central and south-east England and may not be representative of the overall veterinary practice structure in England. Case definitions and diagnosis recording relied heavily on the clinical acumen and note-making of attending practitioners. The researchers made no attempts to second-guess underlying disorders in cases with presenting signs (e.g. vomiting) recorded in lieu of formal diagnoses. Inclusion of umbrella terms such as road traffic accident without additional inclusion of the individual specific injuries sustained within the primary event may have reduced the apparent prevalence of fractures and lacerations but avoided multiple counting of disorder events along axes of diagnostic precision. The analyses based on popular breeds were exploratory in nature and should be validated within larger confirmatory studies [114], [115]. Holm adjustments to P-values were used to constrain the number of false-positive findings resulting from interpretation of multiple comparisons [38], [115], [116]. The current study reported prevalence values but effective welfare prioritisation would additionally benefit from the generation of accurate data on disorder severity and duration [117].

Conclusion

This study describes the most frequently recorded disorders in dogs in England and provides a prevalence baseline against which to measure progress in canine health. The most prevalent disorders recorded in dogs attending primary-care veterinary practices in England were otitis externa, periodontal disease and anal sac impaction, and the most prevalent disorder groups were enteropathic, dermatological and musculoskeletal. The head-and-neck was the body location most frequently affected by the disorders recorded, the integument was the most prevalent organ system affected and inflammation was the most prevalent pathophysiologic process. The study identified some evidence that purebred dogs had higher disorder prevalence compared with crossbred dogs. Substantial variation was shown across breeds in their prevalence of common disorders. These results suggest that breeding reforms should target commonly diagnosed complex disorders that are amenable to genetic improvement on a breed-by-breed basis for the greatest population impact. The prevalence information provided by this study fills a crucial data gap. Future studies of disorder severity and duration would augment the current results and contribute to increasingly effective strategies to improve dog welfare based on disorder prioritisation.

Acknowledgments

We thank Peter Dron (RVC) for VetCompass database development and Noel Kennedy (RVC) for software and programming development. We are especially grateful to the Medivet Veterinary Partnership and the other UK practices and clients who are participating in VetCompass.

Funding Statement

This study was part of a Ph.D. study that was financially supported by the RSPCA (http://www.rspca.org.uk/sciencegroup/companionanimals). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Murray JK, Browne WJ, Roberts MA, Whitmarsh A, Gruffydd-Jones TJ (2010) Number and ownership profiles of cats and dogs in the UK. Veterinary Record 166: 163–168. [DOI] [PubMed] [Google Scholar]
  • 2. Asher L, Buckland E, Phylactopoulos CL, Whiting M, Abeyesinghe S, et al. (2011) Estimation of the number and demographics of companion dogs in the UK. BMC Veterinary Research 7: 74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.PFMA (2012) The Pet Food Manufacturers' Association ‘Statistics’. In: Association TPFM, editor: The Pet Food Manufacturers' Association.
  • 4. Ownby DR, Johnson C, Peterson EL (2002) Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. Journal of the American Medical Association 288: 963–972. [DOI] [PubMed] [Google Scholar]
  • 5. Friedmann E, Son H (2009) The human–companion animal bond: how humans benefit. Veterinary Clinics of North America: Small Animal Practice 39: 293–326. [DOI] [PubMed] [Google Scholar]
  • 6. Virués-Ortega J, Buela-Casal G (2006) Psychophysiological effects of human-animal interaction: theoretical issues and long-term interaction effects. Journal of Nervous and Mental Disease 194: 52–57. [DOI] [PubMed] [Google Scholar]
  • 7. Walsh F (2009) Human-animal bonds I: the relational significance of companion animals. Family Process 48: 462–480. [DOI] [PubMed] [Google Scholar]
  • 8. McGreevy PD, Nicholas FW (1999) Some practical solutions to welfare problems in dog breeding. Animal Welfare 8: 329–341. [Google Scholar]
  • 9. Rooney NJ (2009) The welfare of pedigree dogs: cause for concern. Journal of Veterinary Behavior: Clinical Applications and Research 4: 180–186. [Google Scholar]
  • 10.Wayne RK, Leonard JA, Vila C (2006) Genetic analysis of dog domestication. In: Zeder MA, editor. Documenting domestication: new genetic and archaeological paradigms. Berkeley, California: University of California Press. pp. 279–293.
  • 11. Leroy G (2011) Genetic diversity, inbreeding and breeding practices in dogs: results from pedigree analyses. The Veterinary Journal 189: 177–182. [DOI] [PubMed] [Google Scholar]
  • 12. McGreevy PD (2007) Breeding for quality of life. Animal Welfare 16: 125–128. [Google Scholar]
  • 13. Calboli FC, Sampson J, Fretwell N, Balding DJ (2008) Population structure and inbreeding from pedigree analysis of purebred dogs. Genetics 179: 593–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lewis TW (2010) Optimisation of breeding strategies to reduce the prevalence of inherited disease in pedigree dogs. Animal Welfare 19: 93–98. [Google Scholar]
  • 15. Asher L, Diesel G, Summers JF, McGreevy PD, Collins LM (2009) Inherited defects in pedigree dogs. Part 1: disorders related to breed standards. The Veterinary Journal 182: 402–411. [DOI] [PubMed] [Google Scholar]
  • 16. Summers JF, Diesel G, Asher L, McGreevy PD, Collins LM (2010) Inherited defects in pedigree dogs. Part 2: Disorders that are not related to breed standards. The Veterinary Journal 183: 39–45. [DOI] [PubMed] [Google Scholar]
  • 17.Mellersh CS, Ostrander EA (1997) The canine genome. In: Dodds WJ, James EW, editors. Advances in Veterinary Medicine: Academic Press. pp. 191–216. [DOI] [PubMed]
  • 18. Starkey MP, Scase TJ, Mellersh CS, Murphy S (2005) Dogs really are man's best friend: canine genomics has applications in veterinary and human medicine! Briefings in Functional Genomics & Proteomics. 4: 112–128. [DOI] [PubMed] [Google Scholar]
  • 19.BBC (2008) Pedigree Dogs Exposed.
  • 20.Bateson P (2010) Independent inquiry into dog breeding. Cambridge: University of Cambridge.
  • 21.Rooney N, Sargan D (2008) Pedigree dog breeding in the UK: a major welfare concern? Horsham, West Sussex: RSPCA.
  • 22.APGAW (2009) A healthier future for pedigree dogs. London: The Associate Parliamentary Group for Animal Welfare.
  • 23. Collins LM, Asher L, Summers J, McGreevy P (2011) Getting priorities straight: risk assessment and decision-making in the improvement of inherited disorders in pedigree dogs. The Veterinary Journal 189: 147–154. [DOI] [PubMed] [Google Scholar]
  • 24. Collins LM, Asher L, Summers JF, Diesel G, McGreevy PD (2010) Welfare epidemiology as a tool to assess the welfare impact of inherited defects on the pedigree dog population. Animal Welfare 19: 67–75. [Google Scholar]
  • 25. Fleming JM, Creevy KE, Promislow DEL (2011) Mortality in North American dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death. Journal of Veterinary Internal Medicine 25: 187–198. [DOI] [PubMed] [Google Scholar]
  • 26. Adams VJ, Evans KM, Sampson J, Wood JLN (2010) Methods and mortality results of a health survey of purebred dogs in the UK. Journal of Small Animal Practice 51: 512–524. [DOI] [PubMed] [Google Scholar]
  • 27. Egenvall A, Nødtvedt A, Penell J, Gunnarsson L, Bonnett BN (2009) Insurance data for research in companion animals: benefits and limitations. Acta Veterinaria Scandinavica 51: 42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.VetCompass (2013) VetCompass: Health surveillance for UK companion animals. http://wwwrvcacuk/VetCompass. London: RVC Electronic Media Unit.
  • 29.Medivet (2014) Medivet: the veterinary partnership. Medivet Partnership LLP.
  • 30.The VeNom Coding Group (2013) VeNom Veterinary Nomenclature. In: Group TVC, editor. http://wwwvenomcodingorg: VeNom Coding Group.
  • 31. Kearsley-Fleet L, O′Neill DG, Volk HA, Church DB, Brodbelt DC (2013) Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Veterinary Record 172: 338. [DOI] [PubMed] [Google Scholar]
  • 32.Epi Info 7 CDC (2012) Centers for Disease Control and Prevention (US): Introducing Epi Info 7. http://wwwncdcgov/epiinfo/7. Atlanta, Georgia: CDC.
  • 33.Willard MD, Tvedten H (2004) Small animal clinical diagnosis by laboratory methods. St. Louis, Miss.: Saunders.
  • 34. Sleator DD, Endre Tarjan R (1983) A data structure for dynamic trees. Journal of Computer and System Sciences 26: 362–391. [Google Scholar]
  • 35. Irion DN, Schaffer AL, Famula TR, Eggleston ML, Hughes SS, et al. (2003) Analysis of genetic variation in 28 dog breed populations with 100 microsatellite markers. Journal of Heredity 94: 81–87. [DOI] [PubMed] [Google Scholar]
  • 36.The Kennel Club (2012) Kennel Club's Breed Information Centre. In: Club TK, editor. http://wwwthe-kennel-cluborguk/services/public/breed/Defaultaspx. London: The Kennel Club.
  • 37. McMillan FD (2001) Rethinking euthanasia: death as an unintentional outcome. Journal of the American Veterinary Medical Association 219: 1204–1206. [DOI] [PubMed] [Google Scholar]
  • 38. Aickin M, Gensler H (1996) Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. American Journal of Public Health 86: 726–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kirkwood BR, Sterne JAC (2003) Essential Medical Statistics. Oxford: Blackwell Science.
  • 40. Agresti A, Coull BA (1998) Approximate is better than “exact” for interval estimation of binomial proportions. The American Statistician 52: 119–126. [Google Scholar]
  • 41. Hein HE (1963) Abnormalities and defects in pedigree dogs-II. Hereditary aspects of hip dysplasia. Journal of Small Animal Practice 4: 457–462. [Google Scholar]
  • 42. Hodgman SFJ (1963) Abnormalities and defects in pedigree dogs–I. An investigation into the existence of abnormalities in pedigree dogs in the British Isles. Journal of Small Animal Practice 4: 447–456. [Google Scholar]
  • 43. Knight GC (1963) Abnormalities and defects in pedigree dogs–III. Tibio-femoral joint deformity and patella luxation. Journal of Small Animal Practice 4: 463–464. [Google Scholar]
  • 44. Willis MB (1963) Abnormalities and defects in pedigree dogs—V. Cryptorchidism. Journal of Small Animal Practice 4: 469–474. [Google Scholar]
  • 45.BVA/KC (2013) Hip Dysplasia Scheme. In: British Veterinary Association/Kennel Club, editor. London: British Veterinary Association,.
  • 46.BVA/KC (2013) Chiari Malformation/Syringomyelia Scheme (CM/SM Scheme). In: Club BVAK, editor. London: British Veterinary Association.
  • 47.BVA/KC (2013) Elbow Scheme. London: British Veterinary Association.
  • 48.BVA/KC/ISS (2013) Eye Scheme. In: Society BVAKCIS, editor. Loondon: British Veterinary Association,.
  • 49.KC (2013) DNA Screening Schemes and Results. In: The Kennel Club, editor. London: The Kennel Club,.
  • 50.Indrebø A (2007) Animal welfare in modern dog breeding. Acta Veterinaria Scandinavica 50 Supplement S6.
  • 51. Froom P, Froom J (1992) Selection bias in using data from one population to another: common pitfalls in the interpretation of medical literature. Theoretical Medicine 13: 255–259. [DOI] [PubMed] [Google Scholar]
  • 52. Bartlett PC, Van Buren JW, Neterer M, Zhou C (2010) Disease surveillance and referral bias in the veterinary medical database. Preventive Veterinary Medicine 94: 264–271. [DOI] [PubMed] [Google Scholar]
  • 53. Soll-Johanning H, Hannerz H, Tüchsen F (2004) Referral bias in hospital register studies of geographical and industrial differences in health. Danish Medical Bulletin 51: 207–210. [PubMed] [Google Scholar]
  • 54.KC (2013) The Kennel Club. London: The Kennel Club,.
  • 55. Platt S, Freeman J, di Stefani A, Wieczorek L, Henley W (2006) Prevalence of unilateral and bilateral deafness in Border Collies and association with phenotype. Journal of Veterinary Internal Medicine 20: 1355–1362. [DOI] [PubMed] [Google Scholar]
  • 56. Powers MY, Karbe GT, Gregor TP, McKelvie P, Culp WTN, et al. (2010) Evaluation of the relationship between Orthopedic Foundation for Animals' hip joint scores and PennHIP distraction index values in dogs. Journal of the American Veterinary Medical Association 237: 532–541. [DOI] [PubMed] [Google Scholar]
  • 57. Slater MR, Scarlet JM, Donoghue S, Erb HN (1992) The repeatability and validity of a telephone questionnaire on diet and exercise in dogs. Preventive Veterinary Medicine 13: 77–91. [Google Scholar]
  • 58. Pearce N, Checkoway H, Kriebel D (2007) Bias in occupational epidemiology studies. Occupational and Environmental Medicine 64: 562–568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Gobar GM (1998) Program for surveillance of causes of death of dogs, using the Internet to survey small animal veterinarians. Journal of the American Veterinary Medical Association 213: 251–256. [PubMed] [Google Scholar]
  • 60. Hudson JI, Pope HG, Glynn RJ (2005) The cross-sectional cohort study: an underutilized design. Epidemiology (Cambridge, Mass) 16: 355–359. [DOI] [PubMed] [Google Scholar]
  • 61.Dohoo I, Martin W, Stryhn H (2009) Veterinary Epidemiologic Research. Charlottetown, Canada: VER Inc.
  • 62. Aragon CL, Budsberg SC (2005) Applications of evidence-based medicine: cranial cruciate ligament injury repair in the dog. Veterinary Surgery 34: 93–98. [DOI] [PubMed] [Google Scholar]
  • 63. John U, Rumpf H-J, Hapke U (1999) Estimating prevalence of alcohol abuse and dependence in one general hospital: an approach to reduce sample selection bias. Alcohol and Alcoholism 34: 786–794. [DOI] [PubMed] [Google Scholar]
  • 64. Chodick G, Freedman MD, Kwok RK, Fears TR, Linet MS, et al. (2007) Agreement between contemporaneously recorded and subsequently recalled time spent outdoors: implications for environmental exposure studies. Annals of Epidemiology 17: 106–111. [DOI] [PubMed] [Google Scholar]
  • 65.Edney ATB (1997) An observational study of presentation patterns in companion animal veterinary practices in England. London: University of London. 290 p. [Google Scholar]
  • 66.Lund EM (1997) Development and evaluation of a model for diagnostic surveillance in companion animal practice. St Paul: University of Minnesota.
  • 67.Glickman L, Glickman N (2012) The National Companion Animal Surveillance System NCASP. Purdue University. [DOI] [PubMed]
  • 68. Brady S, Norris JM, Kelman M, Ward MP (2012) Canine parvovirus in Australia: the role of socio-economic factors in disease clusters. The Veterinary Journal 193: 522–528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Egenvall A, Bonnett BN, Olson P, Hedhammar Å (1998) Validation of computerized Swedish dog and cat insurance data against veterinary practice records. Preventive Veterinary Medicine 36: 51–65. [DOI] [PubMed] [Google Scholar]
  • 70. Lund EM, Armstrong PJ, Kirk CA, Kolar LM, Klausner JS (1999) Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. Journal of the American Veterinary Medical Association 214: 1336–1341. [PubMed] [Google Scholar]
  • 71. Rust MK (2005) Advances in the control of Ctenocephalides felis (cat flea) on cats and dogs. Trends in Parasitology 21: 232–236. [DOI] [PubMed] [Google Scholar]
  • 72.NOAH (2013) Facts and Figures About the UK Animal Medicines Industry. In: National Office of Animal Health, editor: NOAH,.
  • 73. Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Statistics in Medicine 25: 127–141. [DOI] [PubMed] [Google Scholar]
  • 74. Mandl KD, Overhage JM, Wagner MM, Lober WB, Sebastiani P, et al. (2004) Implementing syndromic surveillance: a practical guide informed by the early experience. Journal of the American Medical Informatics Association 11: 141–150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Dank G, Segev G, Moshe D, Kent MS (2012) Follow-up study comparing necropsy rates and discrepancies between clinical and pathologic diagnoses at a veterinary teaching hospital: 2009 versus 1989 and 1999. Journal of Small Animal Practice 53: 679–683. [DOI] [PubMed] [Google Scholar]
  • 76. Lober WB, Thomas Karras B, Wagner MM, Marc Overhage J, Davidson AJ, et al. (2002) Roundtable on bioterrorism detection: information system–based surveillance. Journal of the American Medical Informatics Association 9: 105–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Egenvall A, Hedhammar A, Bonnett BN, Olson P (2000) Gender, age and breed pattern of diagnoses for veterinary care in insured dogs in Sweden during 1996. Veterinary Record 146: 551–557. [DOI] [PubMed] [Google Scholar]
  • 78. Vilson Å, Bonnett B, Hansson-Hamlin H, Hedhammar Å (2013) Disease patterns in 32,486 insured German Shepherd Dogs in Sweden: 1995–2006. Veterinary Record 173: 116. [DOI] [PubMed] [Google Scholar]
  • 79. Bonnett BN, Egenvall A, Hedhammar Å, Olson P (2005) Mortality in over 350,000 insured Swedish dogs from 1995–2000: I. breed-, gender-, age- and cause-specific rates. Acta Veterinaria Scandinavica 46: 105–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Stone AB, Hautala JA (2008) Meeting Report: Panel on the potential utility and strategies for design and implementation of a National Companion Animal Infectious Disease Surveillance System. Zoonoses and Public Health 55: 378–384. [DOI] [PubMed] [Google Scholar]
  • 81. Neff MW, Rine J (2006) A fetching model organism. Cell 124: 229–231. [DOI] [PubMed] [Google Scholar]
  • 82. Packer RMA, Hendricks A, Burn CC (2012) Do dog owners perceive the clinical signs related to conformational inherited disorders as ‘normal’ for the breed? A potential constraint to improving canine welfare. Animal Welfare 21: 81–93. [Google Scholar]
  • 83. Egenvall A, Bonnett BN, Olson P, Hedhammar Å (2000) Gender, age, breed and distribution of morbidity and mortality in insured dogs in Sweden during 1995 and 1996. Veterinary Record 146: 519–525. [DOI] [PubMed] [Google Scholar]
  • 84. Medzhitov R (2010) Inflammation 2010: new adventures of an old flame. Cell 140: 771–776. [DOI] [PubMed] [Google Scholar]
  • 85. Mountziaris PM, Spicer PP, Kasper FK, Mikos AG (2011) Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Engineering Part B, Reviews 17: 393–402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Rooney NJ, Sargan DR (2010) Welfare concerns associated with pedigree dog breeding in the UK. Animal Welfare 19: 133–140. [Google Scholar]
  • 87. Crispin S (2011) Tackling the welfare issues of dog breeding. Veterinary Record 168: 53. [DOI] [PubMed] [Google Scholar]
  • 88. Anon (2009) Balancing pedigree dog breed standards and animal welfare - is it possible? Veterinary Record 164: 481–482. [DOI] [PubMed] [Google Scholar]
  • 89.Bell J. The clinical truths about pure breeds, mixed breeds, and designer breeds; 2012 Feb 19–23; Las Vegas. 22–23.
  • 90. Page GP, George V, Go RC, Page PZ, Allison DB (2003) “Are we there yet?”: Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. The American Journal of Human Genetics 73: 711–719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Marsella R, Girolomoni G (2009) Canine models of atopic dermatitis: a useful tool with untapped potential. The Journal of Investigative Dermatology 129: 2351–2357. [DOI] [PubMed] [Google Scholar]
  • 92. Albuquerque C, Morinha F, Requicha J, Martins T, Dias I, et al. (2012) Canine periodontitis: the dog as an important model for periodontal studies. The Veterinary Journal 191: 299–305. [DOI] [PubMed] [Google Scholar]
  • 93.Scott DW, Miller WH, Griffin CE, Muller GH (2001) Muller & Kirk's Small Animal Dermatology. Philadelphia: Saunders.
  • 94. Neuber A (2009) Nail diseases in dogs. Companion Animal 14: 56–62. [Google Scholar]
  • 95. Smith FJD (2003) The molecular genetics of keratin disorders. American Journal of Clinical Dermatology 4: 347–364. [DOI] [PubMed] [Google Scholar]
  • 96. Lewis T, Blott S, Woolliams J (2013) Comparative analyses of genetic trends and prospects for selection against hip and elbow dysplasia in 15 UK dog breeds. BMC Genetics 14: 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. German AJ, Hall EJ, Day MJ (2003) Chronic intestinal inflammation and intestinal disease in dogs. Journal of Veterinary Internal Medicine 17: 8–20. [DOI] [PubMed] [Google Scholar]
  • 98. Kathrani A, Werling D, Allenspach K (2011) Canine breeds at high risk of developing inflammatory bowel disease in the south-eastern UK. Veterinary Record 169: 635. [DOI] [PubMed] [Google Scholar]
  • 99. German AJ (2006) The growing problem of obesity in dogs and cats. The Journal of Nutrition 136: 1940S–1946S. [DOI] [PubMed] [Google Scholar]
  • 100. Houlton JE (2008) A survey of gundog lameness and injuries in Great Britain in the shooting seasons 2005/2006 and 2006/2007. Veterinary and comparative Orthopaedics and Traumatology 21: 231–237. [PubMed] [Google Scholar]
  • 101. Lourenço-Martins AM, Delgado E, Neto I, Peleteiro MC, Morais-Almeida M, et al. (2011) Allergic conjunctivitis and conjunctival provocation tests in atopic dogs. Veterinary Ophthalmology 14: 248–256. [DOI] [PubMed] [Google Scholar]
  • 102. Batt RM, Hall EJ (1989) Chronic enteropathies in the dog. Journal of Small Animal Practice 30: 3–12. [Google Scholar]
  • 103. Pedersen HD, Häggström J (2000) Mitral valve prolapse in the dog: a model of mitral valve prolapse in man. Cardiovascular Research 47: 234–243. [DOI] [PubMed] [Google Scholar]
  • 104. Lewis T (2011) Heritability of premature mitral valve disease in Cavalier King Charles Spaniels. The Veterinary Journal 188: 73. [DOI] [PubMed] [Google Scholar]
  • 105. Bellumori TP, Famula TR, Bannasch DL, Belanger JM, Oberbauer AM (2013) Prevalence of inherited disorders among mixed-breed and purebred dogs: 27,254 cases (1995–2010). Journal of the American Veterinary Medical Association 242: 1549–1555. [DOI] [PubMed] [Google Scholar]
  • 106. Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R (2004) Canine and feline diabetes mellitus: nature or nurture? The Journal of Nutrition 134: 2072S–2080S. [DOI] [PubMed] [Google Scholar]
  • 107. Wood JLN (2002) Heritability and epidemiology of canine hip-dysplasia score and its components in Labrador retrievers in the United Kingdom. Preventive Veterinary Medicine 55: 95–108. [DOI] [PubMed] [Google Scholar]
  • 108. Hillier A, Griffin CE (2001) The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology 81: 147–151. [DOI] [PubMed] [Google Scholar]
  • 109. Mellersh C (2012) DNA testing and domestic dogs. Mammalian Genome 23: 109–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Lewis TW (2010) Genetic evaluation of hip score in UK Labrador Retrievers. PLoS One 5. [DOI] [PMC free article] [PubMed]
  • 111. Wilson B, Nicholas FW, Thomson PC (2011) Selection against canine hip dysplasia: success or failure? The Veterinary Journal 189: 160–168. [DOI] [PubMed] [Google Scholar]
  • 112.Gough A, Thomas A (2010) Breed Predispositions to Disease in Dogs and Cats. Chicester, West Sussex: Wiley-Blackwell.
  • 113. Anon (2013) High profile best of breed winners pass vet checks at Crufts. Veterinary Record 172: 277. [DOI] [PubMed] [Google Scholar]
  • 114. Bender R, Lange S (2001) Adjusting for multiple testing - when and how? Journal of Clinical Epidemiology 54: 343–349. [DOI] [PubMed] [Google Scholar]
  • 115. Greenland S (2008) Multiple comparisons and association selection in general epidemiology. International Journal of Epidemiology 37: 430–434. [DOI] [PubMed] [Google Scholar]
  • 116. Feise R (2002) Do multiple outcome measures require p-value adjustment? BMC Medical Research Methodology 2: 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.CAWC (2006) Breeding and welfare in companion animals: welfare aspects of modifications, through selective breeding or biotechnological methods, to the form, function, or behaviour of companion animals. Sidmouth, Devon: Companion Animal Welfare Council.

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES